Cape Investment Advisory, Inc. Charles River Laboratories International, Inc. Transaction History
Cape Investment Advisory, Inc.
- $223 Billion
- Q2 2024
A detailed history of Cape Investment Advisory, Inc. transactions in Charles River Laboratories International, Inc. stock. As of the latest transaction made, Cape Investment Advisory, Inc. holds 142 shares of CRL stock, worth $28,177. This represents 0.01% of its overall portfolio holdings.
Number of Shares
142
Previous 193
26.42%
Holding current value
$28,177
Previous $52.3 Million
43.9%
% of portfolio
0.01%
Previous 0.02%
Shares
5 transactions
Others Institutions Holding CRL
# of Institutions
732Shares Held
51.8MCall Options Held
233KPut Options Held
236K-
Vanguard Group Inc Valley Forge, PA6.1MShares$1.21 Billion0.02% of portfolio
-
Black Rock Inc. New York, NY5.09MShares$1.01 Billion0.02% of portfolio
-
State Street Corp Boston, MA2.09MShares$414 Million0.02% of portfolio
-
Kayne Anderson Rudnick Investment Management LLC Los Angeles, CA1.91MShares$379 Million0.99% of portfolio
-
Clearbridge Investments, LLC New York, NY1.37MShares$272 Million0.24% of portfolio
About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
- Ticker CRL
- Exchange NYSE
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 50,863,300
- Market Cap $10.1B
- Description
- Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...